ArticleReviews in urology2010
Metabolic syndrome and urologic diseases.
Article in Reviews in urology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
53 citing papers in PubMed, 3 syntheses or guidelines pooled it, 132 citations in OpenAlex.
- PEOPLE: Lifestyle and comorbidities as risk factors for pelvic organ prolapse-a systematic review and meta-analysis PEOPLE: PElvic Organ Prolapse Lifestyle comorbiditiEs.International urogynecology journal · 2023Pooled it
- Association between metabolic syndrome components and the risk of developing nephrolithiasis: A systematic review and bayesian meta-analysis.F1000Research · 2021Pooled it
- Metabolic syndrome and nephrolithiasis: a systematic review and meta-analysis of the scientific evidence.Journal of nephrology · 2014Pooled it
- Preclinical animal models of lower urinary tract dysfunction associated with metabolic syndrome.Nature reviews. Urology · 2026Review
- Nationwide cohort analysis of pediatric urolithiasis: long-term metabolic, renal, and cardiovascular outcomes.Pediatric nephrology (Berlin, Germany) · 2026Article
- Article
- Sarcopenia risk as a predictor of urinary incontinence in women aged 50 and older: a cross-sectional analysis.Scientific reports · 2025Observational
- Cardiometabolic Index and Stress Urinary Incontinence in US Women: The Mediating Role of the Triglyceride Glucose Index.International urogynecology journal · 2025Article
- Association between the skeletal muscle-to-visceral fat ratio and kidney stones: a cross-sectional study.Frontiers in nutrition · 2025Article
- Incidence of metabolic syndrome in patients with unilateral or bilateral staghorn renal stones and its impact on percutaneous nephrolithotomy outcomes.BMC urology · 2024Article
- Proton pump inhibitors use is associated with a higher prevalence of kidney stones: NHANES 2007-2018.BMC public health · 2024Article
- Association between body mass index, metabolic syndrome and common urologic conditions: a cross-sectional study using a large multi-institutional database from the United States.Annals of medicine · 2023Article
- Kidney stones are associated with metabolic syndrome in a health screening population: a cross-sectional study.Translational andrology and urology · 2023Article
- Male Urethral Stricture in Patients with Metabolic Syndrome.Urology research & practice · 2023Article
- Higher weight-adjusted waist index is associated with increased likelihood of kidney stones.Frontiers in endocrinology · 2023Article
- Association between body fat distribution and kidney stones: Evidence from a US population.Frontiers in endocrinology · 2022Article
- Article
- Association between metabolic syndrome and psoriasis: a meta-analysis of observational studies with non-psoriasis control groups.Archives of medical science : AMS · 2021Review
- Men's health in Canada: A national survey of urologists.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2021Article
- Metabolic syndrome in women with and without stress urinary incontinence.International urogynecology journal · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metabolic syndrome (MetS) is a complex entity consisting of multiple interrelated factors including insulin resistance, central adiposity, dyslipidemia, endothelial dysfunction and atherosclerotic disease, low-grade inflammation, and in males, low testosterone levels. MetS has been linked to a number of urologic diseases including nephrolithiasis, benign prostatic hyperplasia and lower urinary tract symptoms, erectile dysfunction, male infertility, female incontinence, and prostate cancer. This article reviews the relationships between MetS and these entities. Urologists need to be cognizant of the impact that MetS has on urologic diseases as well as on overall patient health.
Indexed as
Identifiers
21234260PMC3020279W81988862What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.